FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344261010> ?p ?o ?g. }

• W2344261010 abstract "Kras controls many cellular processes such as cell migration and survival. Mutation of Kras to a constitutively active form is a common alteration in lung cancer. Being constantly active results in a hyper activation of downstream signaling cascades, which leads to enhanced tumorigenicity and high metastatic potential. How constitutive Kras activation translates into these different functions, however, remains unclear. Using patient-derived lung cancer cell lines expressing oncogenic KrasV12 we discovered that Kras expression, not transcription, gets up-regulated under long-term culture in 1% O2. We confirmed the in vivo relevance of this finding, staining mouse lung tumors for Kras and Hif1α, as an indicator for hypoxic areas, and found heterogeneous Kras levels throughout the tumors with hot-spots that overlaid with Hif1α expression. Up-regulation of KrasV12 also correlated with a significant increase in growth of tumor-like aggregates in soft-agar assays and a morphological change from adherent single-cells into sphere-like aggregates in cell culture. This morphology was reversible upon knock-down of Kras. Separation of single clones confirmed the relation between adherent and sphere-like morphologies and the level of KrasV12 expression. Interestingly, the expression level of Kras correlated with clonal migration behavior. Low Kras expressers were highly motile whereas high Kras expressers remained stationary in aggregates. In agreement, exogenous expression of KrasV12 in motile, low Kras expressers converted their morphology and migration behavior to sphere-like, stationary aggregates. Using Western blot analysis we found that these changes are due to differences in Erk activation down-stream of Kras. In high Kras expressers Erk is highly phosphorylated which leads to higher Myosin II activity and thus to a contractile, sphere-like morphology with low mobility. Low Kras levels result in less Erk activation and therefore lower Myosin II activity which leads to an adherent, motile phenotype. Using a specific Erk inhibitor, we could convert high Kras expressers into adherent, motile low Kras clones. At the same time we found an adhesion-dependent feedback mechanism which regulates cellular Kras levels. Protein analysis of cells cultured in low adhesion dishes formed spheres and dramatically increased their Kras content. Most interestingly, this increase was reversible by stimulation of adhesion. Additionally, blocking FAK activation in low Kras expressers resulted in up-regulation of Kras and Erk phosphorylation which went along with a switch to sphere-like morphology. Based on these findings we propose a novel mechanism for controlling cancer cell migration by a hypoxia-sensitive, adhesion-dependent Kras switch which makes the cell very adaptable to different environments during the whole process of metastasis. Citation Format: Anette C. Schafer, Meghan Discoll, Ashwathi Mohan, Andrew Ludlow, Wesley Burford, Jerry W. Shay, Gaudenz Danuser. Differential levels of mutated Kras drive lung cancer cell motility and morphology via a hypoxia-sensitive FAK/Erk/Myosin II signaling pathway. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5102. doi:10.1158/1538-7445.AM2015-5102" @default.
• W2344261010 created "2016-06-24" @default.
• W2344261010 creator A5004225269 @default.
• W2344261010 creator A5010227860 @default.
• W2344261010 creator A5010793442 @default.
• W2344261010 creator A5021279758 @default.
• W2344261010 creator A5037958980 @default.
• W2344261010 creator A5064673731 @default.
• W2344261010 creator A5081012778 @default.
• W2344261010 date "2015-08-01" @default.
• W2344261010 modified "2023-09-26" @default.
• W2344261010 title "Abstract 5102: Differential levels of mutated Kras drive lung cancer cell motility and morphology via a hypoxia-sensitive FAK/Erk/Myosin II signaling pathway" @default.
• W2344261010 doi "https://doi.org/10.1158/1538-7445.am2015-5102" @default.
• W2344261010 hasPublicationYear "2015" @default.
• W2344261010 type Work @default.
• W2344261010 sameAs 2344261010 @default.
• W2344261010 citedByCount "1" @default.
• W2344261010 countsByYear W23442610102017 @default.
• W2344261010 crossrefType "proceedings-article" @default.
• W2344261010 hasAuthorship W2344261010A5004225269 @default.
• W2344261010 hasAuthorship W2344261010A5010227860 @default.
• W2344261010 hasAuthorship W2344261010A5010793442 @default.
• W2344261010 hasAuthorship W2344261010A5021279758 @default.
• W2344261010 hasAuthorship W2344261010A5037958980 @default.
• W2344261010 hasAuthorship W2344261010A5064673731 @default.
• W2344261010 hasAuthorship W2344261010A5081012778 @default.
• W2344261010 hasConcept C121608353 @default.
• W2344261010 hasConcept C1491633281 @default.
• W2344261010 hasConcept C185592680 @default.
• W2344261010 hasConcept C2781187634 @default.
• W2344261010 hasConcept C502942594 @default.
• W2344261010 hasConcept C526805850 @default.
• W2344261010 hasConcept C54355233 @default.
• W2344261010 hasConcept C57074206 @default.
• W2344261010 hasConcept C58207958 @default.
• W2344261010 hasConcept C62112901 @default.
• W2344261010 hasConcept C62478195 @default.
• W2344261010 hasConcept C81885089 @default.
• W2344261010 hasConcept C86803240 @default.
• W2344261010 hasConcept C95444343 @default.
• W2344261010 hasConceptScore W2344261010C121608353 @default.
• W2344261010 hasConceptScore W2344261010C1491633281 @default.
• W2344261010 hasConceptScore W2344261010C185592680 @default.
• W2344261010 hasConceptScore W2344261010C2781187634 @default.
• W2344261010 hasConceptScore W2344261010C502942594 @default.
• W2344261010 hasConceptScore W2344261010C526805850 @default.
• W2344261010 hasConceptScore W2344261010C54355233 @default.
• W2344261010 hasConceptScore W2344261010C57074206 @default.
• W2344261010 hasConceptScore W2344261010C58207958 @default.
• W2344261010 hasConceptScore W2344261010C62112901 @default.
• W2344261010 hasConceptScore W2344261010C62478195 @default.
• W2344261010 hasConceptScore W2344261010C81885089 @default.
• W2344261010 hasConceptScore W2344261010C86803240 @default.
• W2344261010 hasConceptScore W2344261010C95444343 @default.
• W2344261010 hasLocation W23442610101 @default.
• W2344261010 hasOpenAccess W2344261010 @default.
• W2344261010 hasPrimaryLocation W23442610101 @default.
• W2344261010 hasRelatedWork W1967381696 @default.
• W2344261010 hasRelatedWork W1971805819 @default.
• W2344261010 hasRelatedWork W1991037807 @default.
• W2344261010 hasRelatedWork W2022796808 @default.
• W2344261010 hasRelatedWork W2025254642 @default.
• W2344261010 hasRelatedWork W2027877570 @default.
• W2344261010 hasRelatedWork W2040066617 @default.
• W2344261010 hasRelatedWork W2047725331 @default.
• W2344261010 hasRelatedWork W2070280275 @default.
• W2344261010 hasRelatedWork W2102005820 @default.
• W2344261010 hasRelatedWork W2231721598 @default.
• W2344261010 hasRelatedWork W2464767256 @default.
• W2344261010 hasRelatedWork W2565304789 @default.
• W2344261010 hasRelatedWork W2602833072 @default.
• W2344261010 hasRelatedWork W2810897738 @default.
• W2344261010 hasRelatedWork W2994705480 @default.
• W2344261010 hasRelatedWork W3026197278 @default.
• W2344261010 hasRelatedWork W3036847483 @default.
• W2344261010 hasRelatedWork W3084359941 @default.
• W2344261010 hasRelatedWork W2182442858 @default.
• W2344261010 isParatext "false" @default.
• W2344261010 isRetracted "false" @default.
• W2344261010 magId "2344261010" @default.
• W2344261010 workType "article" @default.